Analytical Data
-
Gene name
YWHAG
- Application
-
Alternative Names
YWHAG；14-3-3 Protein gamma
-
Species
Human
-
Source
E. coli
-
Tag
C-his
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P61981
-
Expression Region
1-247aa
-
AA Sequence
MVDREQLVQK ARLAEQAERY DDMAAAMKNV TELNEPLSNE ERNLLSVAYK NVVGARRSSW RVISSIEQKT SADGNEKKIE MVRAYREKIE KELEAVCQDV LSLLDNYLIK NCSETQYESK VFYLKMKGDY YRYLAEVATG EKRATVVESS EKAYSEAHEI SKEHMQPTHP IRLGLALNYS VFYYEIQNAP EQACHLAKTA FDDAIAELDT LNEDSYKDST LIMQLLRDNL TLWTSDQQDD DGGEGNN
-
Molecular Weight
28 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
YWHAG is a member of the 14-3-3 protein family, which plays a critical role in various cellular processes, including cell cycle regulation, signal transduction, and apoptosis. Research on YWHAG has gained attention due to its involvement in multiple diseases, particularly cancer and neurodegenerative disorders. This protein acts as a scaffold that interacts with a wide range of partner proteins, influencing their function and stability. Understanding the molecular mechanisms behind YWHAG's interactions can provide insights into its role in disease progression and potential therapeutic targets. Recent studies have focused on the structural characterization and functional analysis of recombinant YWHAG proteins. These investigations aim to elucidate how alterations in YWHAG expression or function can contribute to pathological conditions. Moreover, recombinant YWHAG proteins have valuable applications in developing predictive biomarkers and innovative treatments. Thus, the study of YWHAG, particularly through recombinant techniques, is essential for advancing our understanding of its biological significance and therapeutic potential.
